J.Jill Stock Discounts Some Operational Deleverage, May Become An Opportunity

Posted Jun 12 by Two Blokes

J.Jill's Q1 comps declined sharply, with management guiding for continued weakness and lack of assortment newn

Source: Two Blokes Trading

Boeing stock plummets after Air India crash, dealing major setback as new leadership tries to rebuild trust

Posted Jun 12 by Two Blokes

The fatal crash tarnishes the Dreamliner jet's safety record and muddies CEO Kelly Orthberg efforts to ramp up

Source: Two Blokes Trading

SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization

Posted Jun 12 by Two Blokes

Simulations Plus lowers FY25 revenue forecast and restructures operations as biotech headwinds hit services de

Source: Two Blokes Trading

Will Strong TASER Demand Continue to Guide Axon's Connected Devices Unit?

Posted Jun 12 by Two Blokes

AXON sees surging demand for TASER devices and body cameras, fueling strong momentum in its Connected Devices

Source: Two Blokes Trading

2 Real Estate Development Stocks to Consider Despite Industry Woes

Posted Jun 12 by Two Blokes

Despite industry woes, healthy demand for certain real estate categories and limited supply bode well for Real

Source: Two Blokes Trading

C3.ai vs. SoundHound: Which AI Stock Has More Upside Right Now?

Posted Jun 12 by Two Blokes

The AI stock outpaces SOUN with federal wins, deeper partnerships and broad enterprise AI adoption.

Source: Two Blokes Trading

Apple Hospitality Expands Portfolio With Acquisition in Tampa

Posted Jun 12 by Two Blokes

APLE adds a Tampa Hilton asset for $18.8M, tapping into the city's booming demand drivers and strategic growth

Source: Two Blokes Trading

Leading bank sees AstraZeneca upside seen in hypertension drug, tempers lung cancer hopes

Posted Jun 12 by Two Blokes

UBS has reiterated its 'buy' rating on AstraZeneca PLC (LSE:AZN) with a 12-month price target of 14,200p, offe

Source: Two Blokes Trading

EyePoint Stock: Retaining My 'Risky Buy' Call - Pivotal Data Due Early 2026

Posted Jun 12 by Two Blokes

EyePoint Pharmaceuticals, Inc.'s Duravyu shows promising Phase 2 results in DME, supporting a slightly risky '

Source: Two Blokes Trading

Altigen Technologies Launches Next-Gen MaxCloud UC to Boost Resiliency, Simplicity, and Performance

Posted Jun 12 by Two Blokes

New architecture and enhanced features streamline operations and elevate the user experience NEWARK, CA / ACCE

Source: Two Blokes Trading

Why AAL Stock Is A Risky Bet

Posted Jun 12 by Two Blokes

American Airlines (NASDAQ:AAL) shares are currently priced around $11.10, reflecting a 35% decline this year,

Source: Two Blokes Trading

What Drove Meta Stock's 2x Rise?

Posted Jun 12 by Two Blokes

META Platforms stock (NASDAQ: META) has witnessed a substantial increase, spurred by investor enthusiasm over

Source: Two Blokes Trading